Dannex Ayrton Starwin (DASPHARMA) share price
Dannex Ayrton Starwin Plc · Ghana Stock Exchange · Health Care
GHS 1.10
-0.02 (-1.79%)
official close, 13 November 2026
Dannex Ayrton Starwin (Dannex Ayrton Starwin Plc) last traded at GHS 1.10 on the Ghana Stock Exchange, down 1.79% on the day. Over the past year it has traded between GHS 0.38 and GHS 1.98.
- Previous close
- GHS 1.12
- Bid / offer
- – / GHS 1.10
- Volume
- 3,783
- 52-week range
- GHS 0.38 – GHS 1.98
- Market value
- GHS 93.24 m
- P/E
- 27.92
- Dividend per share
- –
- Dividend yield
- –
- Earnings per share
- GHS 0.0394
- Shares in issue
- 84,765,898
- Sector
- Health Care
- Industry
- –
Track your GSE shares for free
Enter what you bought and Goldust values it at every close, after fees. Price alerts on your phone, the whole market on one map, and every company announcement. No account needed to start.
Recent closing prices
| Date | Close (GHS) | Change | Volume |
|---|---|---|---|
| 13 November 2026 | 1.10 | -0.02 | 3,783 |
| 12 November 2026 | 1.12 | -0.02 | 8,010 |
| 11 November 2026 | 1.14 | 0.00 | 506 |
| 10 November 2026 | 1.14 | +0.02 | 22,740 |
| 9 November 2026 | 1.12 | +0.08 | 12,774 |
| 6 November 2026 | 1.04 | +0.09 | 6,481 |
| 5 November 2026 | 0.95 | 0.00 | 6,661 |
| 4 November 2026 | 0.95 | +0.02 | 6,542 |
| 3 November 2026 | 0.93 | 0.00 | 5,652 |
| 2 November 2026 | 0.93 | 0.00 | 0 |
Latest announcements
- Results Unaudited Financial Statements for the Period Ended 30 September 2026 30 October 2026
- Leadership Notification of Appointment of New External Auditors 1 October 2026
- Results Unaudited Financial Statements for the Period Ended 30 June 2026 31 July 2026
- Meeting Notice of Annual General Meeting 6 July 2026
- Results Unaudited Financial Statements for the Period Ended 31 March 2026 4 May 2026
- Results Annual Report and Financial Statements for the Year Ended 31 December 2025 4 May 2026
- Results (Daspharma)- Extension of Time for the Publication of Full Year 2025 Audited Financial Statements 27 March 2026
- Results Unaudited Financial Statements for the Year Ended December 31, 2025 30 January 2026
Other Health Care stocks on the GSE
- Intravenous Infusions (IIL) 0.55 +10.00%
